BRIEF-Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026

Reuters2026/10/25 11:01

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Agenus Inc AGEN.O:

AGENUS REPORTS 72% OF PATIENTS WITH LOCALLY ADVANCED DMMR COLON CANCER HAD NO CANCER REMAINING AT SURGERY FOLLOWING SIX WEEKS OF BOT+BAL IN PHASE 2 NEOASIS STUDY AT ESMO 2026

Source text: ID:nBw73zhM8a

Further company coverage: AGEN.O

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRIEF-Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026

You may also like

Crypto prices